Please login to the form below

Not currently logged in
Email:
Password:

Ionis says rare disease drug works, but safety concerns linger

Ionis logoInotersen has been linked to cases of thrombocytopenia

Biogen hands out $120m upfront for Remedy stroke drug

Biogen Idec buildingCirara vying to be first new treatment since the 1990s

Lilly set to head to regulators with CGRP migraine drug

Eli Lilly HQGathers three positive late-stage trials of galcanezumab as it chases Amgen

AZ buoyed by Imfinzi lung cancer trial

AstraZeneca AZPhase III study shows PD-L1 inhibitor increased progression-free survival

GSK's Nucala posts mixed results in COPD

GSK - logo on buildingConflicting late-stage trials throw doubt on its prospects

INC Research to merge with InVentiv Health

INC_ResearchCombined will be second-largest outsourcing provider after QuintilesIMS

AZ trial adds to pessimism about anti-IL-13 asthma drugs

AstraZeneca AZFirm's IL-13 inhibitor failed to reduce the number of asthma attacks compared to placebo

Tecentriq bladder cancer approval in doubt after trial failure

Roche Basel SwitzerlandThe PD-L1 inhibitor failed to extend overall survival in a phase III study

Riding the wave of digital disruption

The challenges and rewards of meeting consumer expectations

  • Real-world evidence

    Companies are now recruiting high-level executives to lead well-resourced RWE teams as industry looks to reshape the future

  • The future of biotech

    What impact will the sector, and its R&D performance, have on pharma?

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pulsar

THE SCIENCE BEHIND CREATIVE RESULTS When science meets art there's chemistry. We simply add passion, positivity and a human warmth....

Latest intelligence

Digital storytelling means building the story around data
The value of digital storytelling in pharma lies in its ability to convert facts and figures into compelling content for patients and HCPs....
Pharma and free medicines: a different perspective
Pfizer have recently announced that they will provide the breast cancer drug, palbociclib, free of charge to patients....
arrow
The false economy of following the leader
How can companies in the sector shake things up?...

Infographics